Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Neuropathic Eye Pain market was valued at US$ 156.4 million in 2022 and is projected to reach US$ 192.3 million by 2029, at a CAGR of 3.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Steroids Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Neuropathic Eye Pain include OKYO Pharma, Ocular Therapeutix, Inc., IACTA Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd, Novartis AG, SALVAT, AbbVie Inc, Bausch &Lomb Incorporated and Kala Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Neuropathic Eye Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuropathic Eye Pain. This report contains market size and forecasts of Neuropathic Eye Pain in global, including the following market information:
Global Neuropathic Eye Pain Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neuropathic Eye Pain companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neuropathic Eye Pain Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Neuropathic Eye Pain Market Segment Percentages, by Type, 2022 (%)
Steroids
Antidepressants
Anticonvulsants
Opioids
Others
Global Neuropathic Eye Pain Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Neuropathic Eye Pain Market Segment Percentages, by Application, 2022 (%)
Clinic
Hospital
Others
Global Neuropathic Eye Pain Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Neuropathic Eye Pain Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neuropathic Eye Pain revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Neuropathic Eye Pain revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
OKYO Pharma
Ocular Therapeutix, Inc.
IACTA Pharmaceuticals, Inc.
Sun Pharmaceutical Industries Ltd
Novartis AG
SALVAT
AbbVie Inc
Bausch &Lomb Incorporated
Kala Pharmaceuticals
Spectra Vision Care
AlconLaboratories
BRIM Biotechnology Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Neuropathic Eye Pain, market overview.
Chapter 2: Global Neuropathic Eye Pain market size in revenue.
Chapter 3: Detailed analysis of Neuropathic Eye Pain company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Neuropathic Eye Pain in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Neuropathic Eye Pain Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neuropathic Eye Pain Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neuropathic Eye Pain Overall Market Size
2.1 Global Neuropathic Eye Pain Market Size: 2022 VS 2029
2.2 Global Neuropathic Eye Pain Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neuropathic Eye Pain Players in Global Market
3.2 Top Global Neuropathic Eye Pain Companies Ranked by Revenue
3.3 Global Neuropathic Eye Pain Revenue by Companies
3.4 Top 3 and Top 5 Neuropathic Eye Pain Companies in Global Market, by Revenue in 2022
3.5 Global Companies Neuropathic Eye Pain Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neuropathic Eye Pain Players in Global Market
3.6.1 List of Global Tier 1 Neuropathic Eye Pain Companies
3.6.2 List of Global Tier 2 and Tier 3 Neuropathic Eye Pain Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neuropathic Eye Pain Market Size Markets, 2022 & 2029
4.1.2 Steroids
4.1.3 Antidepressants
4.1.4 Anticonvulsants
4.1.5 Opioids
4.1.6 Others
4.2 By Type - Global Neuropathic Eye Pain Revenue & Forecasts
4.2.1 By Type - Global Neuropathic Eye Pain Revenue, 2018-2023
4.2.2 By Type - Global Neuropathic Eye Pain Revenue, 2024-2029
4.2.3 By Type - Global Neuropathic Eye Pain Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neuropathic Eye Pain Market Size, 2022 & 2029
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Neuropathic Eye Pain Revenue & Forecasts
5.2.1 By Application - Global Neuropathic Eye Pain Revenue, 2018-2023
5.2.2 By Application - Global Neuropathic Eye Pain Revenue, 2024-2029
5.2.3 By Application - Global Neuropathic Eye Pain Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Neuropathic Eye Pain Market Size, 2022 & 2029
6.2 By Region - Global Neuropathic Eye Pain Revenue & Forecasts
6.2.1 By Region - Global Neuropathic Eye Pain Revenue, 2018-2023
6.2.2 By Region - Global Neuropathic Eye Pain Revenue, 2024-2029
6.2.3 By Region - Global Neuropathic Eye Pain Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Neuropathic Eye Pain Revenue, 2018-2029
6.3.2 US Neuropathic Eye Pain Market Size, 2018-2029
6.3.3 Canada Neuropathic Eye Pain Market Size, 2018-2029
6.3.4 Mexico Neuropathic Eye Pain Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Neuropathic Eye Pain Revenue, 2018-2029
6.4.2 Germany Neuropathic Eye Pain Market Size, 2018-2029
6.4.3 France Neuropathic Eye Pain Market Size, 2018-2029
6.4.4 U.K. Neuropathic Eye Pain Market Size, 2018-2029
6.4.5 Italy Neuropathic Eye Pain Market Size, 2018-2029
6.4.6 Russia Neuropathic Eye Pain Market Size, 2018-2029
6.4.7 Nordic Countries Neuropathic Eye Pain Market Size, 2018-2029
6.4.8 Benelux Neuropathic Eye Pain Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Neuropathic Eye Pain Revenue, 2018-2029
6.5.2 China Neuropathic Eye Pain Market Size, 2018-2029
6.5.3 Japan Neuropathic Eye Pain Market Size, 2018-2029
6.5.4 South Korea Neuropathic Eye Pain Market Size, 2018-2029
6.5.5 Southeast Asia Neuropathic Eye Pain Market Size, 2018-2029
6.5.6 India Neuropathic Eye Pain Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Neuropathic Eye Pain Revenue, 2018-2029
6.6.2 Brazil Neuropathic Eye Pain Market Size, 2018-2029
6.6.3 Argentina Neuropathic Eye Pain Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neuropathic Eye Pain Revenue, 2018-2029
6.7.2 Turkey Neuropathic Eye Pain Market Size, 2018-2029
6.7.3 Israel Neuropathic Eye Pain Market Size, 2018-2029
6.7.4 Saudi Arabia Neuropathic Eye Pain Market Size, 2018-2029
6.7.5 UAE Neuropathic Eye Pain Market Size, 2018-2029
7 Neuropathic Eye Pain Companies Profiles
7.1 OKYO Pharma
7.1.1 OKYO Pharma Company Summary
7.1.2 OKYO Pharma Business Overview
7.1.3 OKYO Pharma Neuropathic Eye Pain Major Product Offerings
7.1.4 OKYO Pharma Neuropathic Eye Pain Revenue in Global Market (2018-2023)
7.1.5 OKYO Pharma Key News & Latest Developments
7.2 Ocular Therapeutix, Inc.
7.2.1 Ocular Therapeutix, Inc. Company Summary
7.2.2 Ocular Therapeutix, Inc. Business Overview
7.2.3 Ocular Therapeutix, Inc. Neuropathic Eye Pain Major Product Offerings
7.2.4 Ocular Therapeutix, Inc. Neuropathic Eye Pain Revenue in Global Market (2018-2023)
7.2.5 Ocular Therapeutix, Inc. Key News & Latest Developments
7.3 IACTA Pharmaceuticals, Inc.
7.3.1 IACTA Pharmaceuticals, Inc. Company Summary
7.3.2 IACTA Pharmaceuticals, Inc. Business Overview
7.3.3 IACTA Pharmaceuticals, Inc. Neuropathic Eye Pain Major Product Offerings
7.3.4 IACTA Pharmaceuticals, Inc. Neuropathic Eye Pain Revenue in Global Market (2018-2023)
7.3.5 IACTA Pharmaceuticals, Inc. Key News & Latest Developments
7.4 Sun Pharmaceutical Industries Ltd
7.4.1 Sun Pharmaceutical Industries Ltd Company Summary
7.4.2 Sun Pharmaceutical Industries Ltd Business Overview
7.4.3 Sun Pharmaceutical Industries Ltd Neuropathic Eye Pain Major Product Offerings
7.4.4 Sun Pharmaceutical Industries Ltd Neuropathic Eye Pain Revenue in Global Market (2018-2023)
7.4.5 Sun Pharmaceutical Industries Ltd Key News & Latest Developments
7.5 Novartis AG
7.5.1 Novartis AG Company Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Neuropathic Eye Pain Major Product Offerings
7.5.4 Novartis AG Neuropathic Eye Pain Revenue in Global Market (2018-2023)
7.5.5 Novartis AG Key News & Latest Developments
7.6 SALVAT
7.6.1 SALVAT Company Summary
7.6.2 SALVAT Business Overview
7.6.3 SALVAT Neuropathic Eye Pain Major Product Offerings
7.6.4 SALVAT Neuropathic Eye Pain Revenue in Global Market (2018-2023)
7.6.5 SALVAT Key News & Latest Developments
7.7 AbbVie Inc
7.7.1 AbbVie Inc Company Summary
7.7.2 AbbVie Inc Business Overview
7.7.3 AbbVie Inc Neuropathic Eye Pain Major Product Offerings
7.7.4 AbbVie Inc Neuropathic Eye Pain Revenue in Global Market (2018-2023)
7.7.5 AbbVie Inc Key News & Latest Developments
7.8 Bausch &Lomb Incorporated
7.8.1 Bausch &Lomb Incorporated Company Summary
7.8.2 Bausch &Lomb Incorporated Business Overview
7.8.3 Bausch &Lomb Incorporated Neuropathic Eye Pain Major Product Offerings
7.8.4 Bausch &Lomb Incorporated Neuropathic Eye Pain Revenue in Global Market (2018-2023)
7.8.5 Bausch &Lomb Incorporated Key News & Latest Developments
7.9 Kala Pharmaceuticals
7.9.1 Kala Pharmaceuticals Company Summary
7.9.2 Kala Pharmaceuticals Business Overview
7.9.3 Kala Pharmaceuticals Neuropathic Eye Pain Major Product Offerings
7.9.4 Kala Pharmaceuticals Neuropathic Eye Pain Revenue in Global Market (2018-2023)
7.9.5 Kala Pharmaceuticals Key News & Latest Developments
7.10 Spectra Vision Care
7.10.1 Spectra Vision Care Company Summary
7.10.2 Spectra Vision Care Business Overview
7.10.3 Spectra Vision Care Neuropathic Eye Pain Major Product Offerings
7.10.4 Spectra Vision Care Neuropathic Eye Pain Revenue in Global Market (2018-2023)
7.10.5 Spectra Vision Care Key News & Latest Developments
7.11 AlconLaboratories
7.11.1 AlconLaboratories Company Summary
7.11.2 AlconLaboratories Business Overview
7.11.3 AlconLaboratories Neuropathic Eye Pain Major Product Offerings
7.11.4 AlconLaboratories Neuropathic Eye Pain Revenue in Global Market (2018-2023)
7.11.5 AlconLaboratories Key News & Latest Developments
7.12 BRIM Biotechnology Inc
7.12.1 BRIM Biotechnology Inc Company Summary
7.12.2 BRIM Biotechnology Inc Business Overview
7.12.3 BRIM Biotechnology Inc Neuropathic Eye Pain Major Product Offerings
7.12.4 BRIM Biotechnology Inc Neuropathic Eye Pain Revenue in Global Market (2018-2023)
7.12.5 BRIM Biotechnology Inc Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
